Mol chief Hernádi to be Chairman of Board of Trustees.
Dividend in focus.
The rating is 'overweight'.
Via convertible notes.
From 2018 profits. Invitation for AGM shows.
One-off item dents profits.
Richter to publish Q4 2018 earnings report this week.
New technical director to be appointed.
With Dutch Pantarhei Bioscience on sale of combined oral contraceptive.
Recommendation remains 'Hold', though.
Drop in Esmya sales weigh on results.
Pharma company to publish earnings report early on Thursday.
Pharmafarm is back in business.
Signs license and distribution agreement.
Women's Healthcare portfolio expanded.
J.P. Morgan also cuts rating.
U.S. FDA rejects application by Allergan.
Richter pampers shareholders with positive surprises.
There are some crucial questions, though.
Mol is also set to release earnings report this week.